Ocular Graft-Versus-Host Disease Topic Review

[1] Murali AR(2016)Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management Transplantation. 100 2661-2670

[2] Chandra S(2012)Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant Am J Hematol 87 219-221

[3] Stewart Z(2015)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report Biol Blood Marrow Transplant 21 389-401.e1

[4] Blazar BR(2005)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report Biol Blood Marrow Transplant 11 945-956

[5] Farooq U(2012)Impact of ocular surface symptoms on quality of life in a United States veterans affairs population Am J Ophthalmol 153 1061-1066.e3

[6] Ince MN(2015)Vision-related quality of life in patients with ocular graft-versus-host disease Ophthalmology. 122 1669-1674

[7] Dunkelberg J(2018)Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center Ocul Surf. 16 314-321

[8] Fidler C(2010)Ocular graft-versus-host disease after allogeneic stem cell transplantation Cornea 29 758-763

[9] Klumpp T(2012)Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria Bone Marrow Transplant 47 1470-1473

[10] Mangan K(2013)Prevalence of hematopoietic cell transplant survivors in the United States Biol Blood Marrow Transplant 19 1498-1501

[1] Murali AR(2016)Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management Transplantation. 100 2661-2670

[2] Chandra S(2012)Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant Am J Hematol 87 219-221

[3] Stewart Z(2015)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report Biol Blood Marrow Transplant 21 389-401.e1

[4] Blazar BR(2005)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report Biol Blood Marrow Transplant 11 945-956

[5] Farooq U(2012)Impact of ocular surface symptoms on quality of life in a United States veterans affairs population Am J Ophthalmol 153 1061-1066.e3

[6] Ince MN(2015)Vision-related quality of life in patients with ocular graft-versus-host disease Ophthalmology. 122 1669-1674

[7] Dunkelberg J(2018)Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center Ocul Surf. 16 314-321

[8] Fidler C(2010)Ocular graft-versus-host disease after allogeneic stem cell transplantation Cornea 29 758-763

[9] Klumpp T(2012)Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria Bone Marrow Transplant 47 1470-1473

[10] Mangan K(2013)Prevalence of hematopoietic cell transplant survivors in the United States Biol Blood Marrow Transplant 19 1498-1501